Login / Signup

Efficacy of Topical Azithromycin versus Systemic Doxycycline in Treatment of Meibomian Gland Dysfunction.

Marwa Aly ZakyAdel Galal ZakyMoataz Fayez ElsawyKareem Fatehy ShehataMohamed Samy Abd Elaziz
Published in: Journal of ophthalmology (2023)
Meibomian gland dysfunction (MGD) could be treated effectively with oral doxycycline and topical azithromycin by improving symptoms, clinical signs, and stabilization of tear film. Moreover, the topical azithromycin group seemed to be superior over the oral doxycycline group in improving the quality of tear film in the short term, having fewer side effects, more compliance, and better tolerability.
Keyphrases
  • wound healing
  • oxidative stress
  • room temperature
  • reduced graphene oxide
  • open label
  • clinical trial
  • gold nanoparticles
  • newly diagnosed
  • double blind
  • replacement therapy
  • placebo controlled
  • drug induced